Monoamine-oxidase B Inhibitors
NICE guidance
NG71 Parkinson's disease in adults, July 2017
Calculator for inpatients who cannot take their usual oral Parkinson's medication orally - guidance for switching to liquid/dispersible preparations and/or patches if needed
Safinamide to be prescribed third line for patients with Parkinson’s disease that is refractory to other oral treatments and the next step would be to start advanced, non-oral treatments. To be initiated by specialists in Neurology & Healthcare of Older People and continued in primary care.
| Pack |
|---|
| 100 tablet |
| 30 tablet |
| 56 tablet |
| 60 tablet |
| Pack |
|---|
| 100 tablet |
| 28 tablet |
| 30 tablet |
| Pack |
|---|
| 30 tablet (3 x 10 tablets) |
| Pack |
|---|
| 30 tablet (3 x 10 tablets) |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary